Rahul Ramachandran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rahul Ramachandran has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Khaja Shameem Mohammed Abdul
Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China
1 shared publication - Rajeev Vikram
Institute of Biomedical Sciences
1 shared publication
Latest Publications
- 20 July 2014
- Published by Springer Nature in Breast Cancer
- Vol. 21 (5) , 515-521
Functional significance of long non-coding RNAs in breast cancer
Most of the genome is transcribed to transcripts of no protein-coding potential. However, these transcripts do not represent transcriptional ‘noise’, rather they play an important role in cellular metabolism and development. Non-coding transcripts of 200 bases to 100 kb length are termed as long non-coding RNAs, majority of which are yet to be characterised thoroughly. Long non-coding RNAs (lncRNAs) play a significant role in cellular process ranging from transcriptional to post-transcriptional regulation. In this review, we highlight the recent efforts to characterise the major functions of lncRNAs in breast cancer. lncRNA expression is altered in several cancer types. Further, the aberrant regulation of lncRNAs promotes tumour development as they are involved in several cancer-associated pathways.
- 20 July 2014
- Published by Springer Nature in Breast Cancer
- Vol. 21 (5) , 515-521
Functional significance of long non-coding RNAs in breast cancer
Most of the genome is transcribed to transcripts of no protein-coding potential. However, these transcripts do not represent transcriptional ‘noise’, rather they play an important role in cellular metabolism and development. Non-coding transcripts of 200 bases to 100 kb length are termed as long non-coding RNAs, majority of which are yet to be characterised thoroughly. Long non-coding RNAs (lncRNAs) play a significant role in cellular process ranging from transcriptional to post-transcriptional regulation. In this review, we highlight the recent efforts to characterise the major functions of lncRNAs in breast cancer. lncRNA expression is altered in several cancer types. Further, the aberrant regulation of lncRNAs promotes tumour development as they are involved in several cancer-associated pathways.